Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Fractionated stereotactic radiosurgery for the treatment of meningiomas

Bria Carley, Wegner Rodney E, Clump David A, Vargo John A, Mintz Arlan H, Heron Dwight E, Burton Steven A

Year : 2011| Volume: 7| Issue : 1 | Page no: 52-57

   This article has been cited by
 
1 Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers,Igor Barani,Marc Chamberlain,Thomas J. Kaley,Michael McDermott,Jeffrey Raizer,David Schiff,Damien C. Weber,Patrick Y. Wen,Michael A. Vogelbaum
Journal of Neurosurgery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
Nunes, F.P. and Merker, V.L. and Jennings, D. and Caruso, P.A. and di Tomaso, E. and Muzikansky, A. and Barker II, F.G. and Stemmer-Rachamimov, A. and Plotkin, S.R.
PLoS ONE. 2013; 8(3)
[Pubmed]  [Google Scholar]
3 Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors
Kocher, M. and Treuer, H. and Hoevels, M. and Semrau, R. and Sturm, V. and Mueller, R.-P.
Strahlentherapie und Onkologie. 2013; 189(2): 137-141
[Pubmed]  [Google Scholar]
4 Surgical Approaches to Central Skull Base and Postsurgical Imaging
Mohamad R. Chaaban,Bradford A. Woodworth,Surjith Vattoth,R. Shane Tubbs,Kristen Owen Riley
Seminars in Ultrasound, CT and MRI. 2013; 34(5): 476
[Pubmed]  [Google Scholar] [DOI]
5 The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection
Douglas A. Hardesty,Andrew B. Wolf,David G. Brachman,Heyoung L. McBride,Emad Youssef,Peter Nakaji,Randall W. Porter,Kris A. Smith,Robert F. Spetzler,Nader Sanai
Journal of Neurosurgery. 2013; 119(2): 475
[Pubmed]  [Google Scholar] [DOI]
6 Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors
M. Kocher,H. Treuer,M. Hoevels,R. Semrau,V. Sturm,R.-P. Mueller
Strahlentherapie und Onkologie. 2013; 189(2): 137
[Pubmed]  [Google Scholar] [DOI]
7 Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
# Blakeley, J.O., Evans, D.G., Adler, J., Brackmann, D., Chen, R., Ferner, R.E., Hanemann, C.O., (...), Giovannini, M.
American Journal of Medical Genetics, Part A. 2012; 158: 24-41
[Pubmed]  [Google Scholar]
8 Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
Jaishri O. Blakeley,D. Gareth Evans,John Adler,Derald Brackmann,Ruihong Chen,Rosalie E. Ferner,C. Oliver Hanemann,Gordon Harris,Susan M. Huson,Abraham Jacob,Michel Kalamarides,Matthias A. Karajannis,Bruce R. Korf,Victor-Felix Mautner,Andrea I. McClatchey,Harry Miao,Scott R. Plotkin,William Slattery,Anat O. Stemmer-Rachamimov,D. Bradley Welling,Patrick Y. Wen,Brigitte Widemann,Kim Hunter-Schaedle,Marco Giovannini
American Journal of Medical Genetics Part A. 2012; 158A(1): 24
[Pubmed]  [Google Scholar] [DOI]

 

Read this article